Loss of LPAR6 and CAB39L dysregulates the basal-to-luminal urothelial differentiation program, contributing to bladder carcinogenesis
Authors:
Open Access
- 25 April 2024
- journal article
- research article
- Published by Elsevier in Cell Reports
- Vol. 43 (5) , 114146
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute
- Cancer Prevention and Research Institute of Texas
This publication has 81 references indexed in Scilit:
- Inhibition of lysophosphatidic acid receptor 6 upregulated by the choline‐deficient l‐amino acid‐defined diet prevents hepatocarcinogenesis in miceMolecular Carcinogenesis, 2023
- Lysophosphatidic acid receptor 6 regulated by miR-27a-3p attenuates tumor proliferation in breast cancerClinical and Translational Oncology, 2021
- Frameshift Mutations of CAB39L, an Activator of LKB1 Tumor Suppressor, in Gastric and Colorectal CancersPathology and Oncology Research, 2015
- Tumor-secreted lysophostatidic acid accelerates hepatocellular carcinoma progression by promoting differentiation of peritumoral fibroblasts in myofibroblastsHepatology, 2011
- Distinct Expression Profiles of p63 Variants during Urothelial Development and Bladder Cancer ProgressionThe American Journal of Pathology, 2011
- Integrated genomic and transcriptional analysis of the in vitro evolution of telomerase‐immortalized urothelial cells (TERT‐NHUC)Genes, Chromosomes and Cancer, 2009
- Identification and functional characterization of the novel acute monocytic leukemia associated antigen MLAA-34Cancer Immunology, Immunotherapy, 2008
- Genetic modeling of human urinary bladder carcinogenesisGenes, Chromosomes and Cancer, 2000
- Carcinogen exposure, p53 alteration, and K-ras mutation in synchronous multiple primary lung carcinomaCancer, 1999
- Mapping Cancerous and Precancerous Bladder ChangesJAMA, 1974